Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

Feature | Richard R. Rogoski

When it comes to treating patients suffering from heart failure, which is typically defined as a heart whose ...

Home May 07, 2007
Home
News

May 1, 2007 — Cardiome Pharma Corp. says this week it has received exclusive worldwide rights to Eli Lilly & Co.'s ...

Home April 30, 2007
Home
News

April 26, 2007 — Cardiologist Lee A. Surkin, M.D., FAAC, is set to launch a new line of cardiac nutritional supplements ...

Home April 25, 2007
Home
News

April 26, 2007 — Bristol-Myers Squibb Co. and Pfizer Inc. have announced a worldwide collaboration to develop and ...

Home April 25, 2007
Home
News

April 25, 2007 — CV Therapeutics Inc. has announced that data from the MERLIN TIMI-36 study will be published in this ...

Home April 24, 2007
Home
News

April 25, 2007 — Bristol-Myers Squibb will host a groundbreaking ceremony May 2 for its new biologics facility in Devens ...

Home April 24, 2007
Home
News

April 19, 2007 — Schering-Plough Corp. has announced plans to initiate two global Phase III large-scale clinical ...

Home April 18, 2007
Home
News

April 19, 2007 — Following Tuesday’s seizing of all implantable medical devices from Shelhigh Inc., Union, NJ, by FDA ...

Home April 18, 2007
Home
News

April 16, 2007 — LegalView.com has added a database of up-to-date information about FDA-approved drugs, which ...

Home April 15, 2007
Home
News

April 9, 2007 — The FDA has approved Abbott's new coated Niaspan (niacin extended-release tablets) for boosting HDL ...

Home April 07, 2007
Home
Technology

Pfizer says the FDA has approved the company’s Lipitor (atorvastatin calcium) Tablets to reduce the risk of ...

Home March 22, 2007
Home
News

March 22, 2007 — Pfizer says the FDA has approved the company’s Lipitor (atorvastatin calcium) Tablets to reduce the ...

Home March 21, 2007
Home
Deadly Connection:  Hypothyroidism and Heart Disease
Feature | Yue-Feng Chen, M.D., Ph.D. and A. Martin Gerdes, Ph.D.

Thyroid hormone has multiple effects on the cardiovascular system. These include increased cardiac contractility ...

Home March 15, 2007
Home
News

March 9, 2007 — Pfizer has announced that the FDA has approved Lipitor (atorvastatin calcium) Tablets to reduce the risk ...

Home March 08, 2007
Home
News

Feb. 6, 2007 — The FDA has issued an approval letter for GlaxoSmithKline’s once-a-day anticoagulant, Arixtra ...

Home February 05, 2007
Home
Subscribe Now